Company: HRTX
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001193125-25-263618
Chunk: 2

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-11-04
Form: 10-Q
Item: Item 1
Chunk 2
---
HERON THERAPEUTICS, INC.

Condensed Consolidated Balance Sheets

(In thousands)

     September 30,2025

     December 31,2024

     (Unaudited)

     (See Note 2)

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     43,068

     $
     25,802

     Short-term investments

     12,419

     33,481

     Accounts receivable, net

     81,047

     78,881

     Inventory, net

     70,025

     53,160

     Prepaid expenses and other current assets

     22,841

     17,690

     Total current assets

     229,400

     209,014

     Property and equipment, net

     12,960

     14,863

     Right-of-use lease assets

     708

     2,787

     Other assets

     5,882

     6,483

     Total assets
      
     $
     248,950

     $
     233,147

     LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

     Current liabilities:

     Accounts payable
      
     $
     12,017

     $
     11,709

     Accrued clinical and manufacturing liabilities

     19,663

     25,402

     Accrued payroll and employee liabilities

     8,748

     9,554

     Other accrued liabilities

     48,500

     41,755

     Current lease liabilities

     780

     3,037

     Total current liabilities

     89,708

     91,457

     Non-current notes payable, net

     107,487

     25,026

     Non-current convertible notes payable, net

     32,176

     149,700

     Other non-current liabilities

     4,694

     615

     Total liabilities

     234,065

     266,798

     Stockholders' equity (deficit):

     Common stock

     1,833

     1,521

     Series A convertible preferred stock

     7,862

     —

     Additional paid-in capital

     1,942,025

     1,